We are working to redefine the treatment of some of the most challenging types of cancer.
For Patients. For Practioners. For the Future.
Our drive is to redefine the treatment of some of the most challenging-to-treat solid tumors. Our proprietary cell therapy platform engineers a patient’s own cells to fight cancer.
Our robust pipeline of cell therapies has the potential to significantly improve the patient’s treatment experience.
Adaptimmune delivers on this personalized approach from discovery through delivery with fully integrated capabilities including research, global clinical development, translational sciences, commercialization and manufacturing.